Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin

American Journal of Physiology - Renal Physiology

Volumn 288, Issue 3 57-3, 2005, Pages

  Fallet, Rachel W ^a   Ikenaga, Hideki ^a   Bast, Joseph P ^a   Carmines, Pamela K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Calcium signaling; Cyclopiazonic acid; Diltiazem; Thapsigargin; Vasoconstriction

Indexed keywords

ARGIPRESSIN; CALCIUM; CYCLOPIAZONIC ACID; DILTIAZEM; THAPSIGARGIN; VOLTAGE GATED CALCIUM CHANNEL; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; INDOLE DERIVATIVE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

AFFERENT ARTERIOLE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; EFFERENT ARTERIOLE; JUXTAGLOMERULAR APPARATUS; KIDNEY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; ANIMAL; BLOOD PRESSURE; CHANNEL GATING; DRUG ANTAGONISM; DRUG EFFECT; KIDNEY CIRCULATION; METABOLISM; MUSCLE CONTRACTION; NEPHRON; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARGININE VASOPRESSIN; ARTERIOLES; BLOOD PRESSURE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM-TRANSPORTING ATPASES; DILTIAZEM; INDOLES; ION CHANNEL GATING; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NEPHRONS; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; THAPSIGARGIN; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 14044273702     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00150.2002     Document Type: Article

References (48)

1. Bührle CP, Hackenthal E, Helmchen U, Lackner K, Nobiling R, Steinhausen M, and Taugner R. The hydronephrotic kidney of the mouse as a tool for intravital microscopy and in vitro electrophysiological studies of renin-containing cells. Lab Invest 54: 462-472, 1986.
2. 2+ efflux in A7r5 rat smooth muscle cells. J Physiol 485: 455-468, 1995.
3. 2+] in renal arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 265: F677-F685, 1993.
4. Carmines PK, Inscho EW, and Censure RC. Arterial pressure effects on preglomerular microvasculature of juxtamedullary nephrons. Am J Physiol Renal Fluid Electrolyte Physiol 258: F94-F102, 1990.
5. Carmines PK and Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am J Physiol Renal Fluid Electrolyte Physiol 256: F1015-F1020, 1989.
6. Carmines PK, Ohishi K, and Ikenaga H. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus. J Clin Invest 98: 2564-2571, 1996.
7. Casellas D and Navar LG. In vitro perfusion of juxtamedullary nephrons in rats. Am J Physiol Renal Fluid Electrolyte Physiol 246: F349-F358, 1984.
8. 2+ handling along the arterial tree: an update including studies in human mesenteric resistance vessels. J Cardiovasc Pharmacol 12: S10-S15, 1988.
9. Conger JD and Falk SA. KCl and angiotensin responses in isolated rat renal arterioles: effects of diltiazem and low-calcium medium. Am J Physiol Renal Fluid Electrolyte Physiol 264: F134-F140, 1993.
10. Cooper CL and Malik KU. Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors. J Pharmacol Exp Ther 229: 139-147, 1984.
11. Edwards RM. Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol Renal Fluid Electrolyte Physiol 244: F526-F534, 1983.
12. Fellner SK and Arendshorst WJ. Capacitative calcium entry in smooth muscle cells from preglomerular vessels. Am J Physiol Renal Physiol 277: F533-F542, 1999.
13. 1 receptors. Am J Physiol Renal Fluid Electrolyte Physiol 271: F304-F313, 1996.
14. Feng JJ and Arendshorst WJ. Calcium signaling mechanisms in renal vascular responses to vasopressin in genetic hypertension. Hypertension 30: 1223-1231, 1997.
15. 2+-transport ATPase in rat skeletal muscle sarcoplasmic reticulum vesicles. Biochem Pharmacol 37: 978-981, 1988.
16. Goligorsky MS, Colflesh D, Gordienko D, and Moore LC. Branching points of renal resistance arteries are enriched in L-type calcium channels and initiate vasoconstriction. Am J Physiol Renal Fluid Electrolyte Physiol 268: F251-F257, 1995.
17. 2+ channel, and it is functionally important in renal afferent arterioles. Circ Res 87: 896-902, 2000.
18. Hansen PB, Jensen BL, Andreasen D, and Skøtt O. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res 89: 630-638, 2001.
19. Harrison-Bernard LM and Carmines PK. Juxtamedullary microvascular responses to arginine vasopressin in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 267: F249-F256, 1994.
20. i responses to ANG II. Am J Physiol Renal Physiol 273: F84-F96, 1997.
21. Ikenaga H, Fallet RW, and Carmines PK. Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANG II in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 271: F365-F373, 1996.
22. Imig JD, Cook AK, and Inscho EW. Postglomerular vasoconstriction to angiotensin II and norepinephrine depends on intracellular calcium release. Gen Pharmacol 34: 409-415, 2001.
23. Inscho EW, Cook AK, Mui V, and Imig JD. Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction. Hypertension 31: 421-428, 1998.
24. 2+ from intracellular stores. Hypertension 29: 222-227, 1997.
25. Inscho EW, Ohishi K, Cook AK, Belott TP, and Navar LG. Calcium activation mechanisms in the renal microvascular response to extracellular ATP. Am J Physiol Renal Fluid Electrolyte Physiol 268: F876-F884, 1995.
26. Iversen BM and Arendshorst WJ. ANG II and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles. Am J Physiol Renal Physiol 274: F498-F508, 1998.
27. 2+ signaling in preglomerular arteriolar smooth muscle cells of genetically hypertensive rats. Am J Physiol Renal Physiol 276: F260-F270, 1999.
28. Knot HJ, de Ree MM, Gahwiler BH, and Ruegg UT. Modulation of electrical activity and of intracellular calcium oscillations of smooth muscle cells by calcium antagonists, agonists, and vasopressin. J Cardiovasc Pharmacol 18, Suppl 10: S7-S14, 1991.
29. Kostrzewska A, Modzelewska B, and Batra S. Source of calcium for contractile responses of large and small human intramyometrial arteries. Hum Reprod 15: 1927-1931, 2000.
30. 2+ entry. Circ Res 87: 551-557, 2000.
31. Loutzenhiser R, Chilton L, and Trottier G. Membrane potential measurements in renal afferent and efferent arterioles: actions of angiotensin II. Am J Physiol Renal Physiol 273: F307-F314, 1997.
32. Loutzenhiser R, Hayashi K, and Epstein M. Divergent effects of KCl-induced depolarization on afferent and efferent arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 257: F561-F564, 1989.
33. Lytton J, Westlin M, and Hanley MR. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 266: 17067-17071, 1991.
34. 2+ permeability of the plasma membrane: comparison of the effects of thapsigargin, 2,5-di-(tert-butyl)-1,4-hydroquinone, and cyclopiazonic acid in rat thymic lymphocytes. J Biol Chem 266: 20856-20862, 1991.
35. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, and Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-536, 1996.
36. Nelson EJ, Li CC, Bangalore R, Benson T, Kass RS, and Hinkle PM. Inhibition of L-type calcium-channel activity by thapsigargin and 2,5-t-butylhydroquinone, but not by cyclopiazonic acid. Biochem J 302: 147-154, 1994.
37. 2 receptors within the renal cortical and medullary circulation. Am J Physiol Regul Integr Comp Physiol 273: R243-R251, 1997.
38. Schrier RW, Briner V, and Caramelo C. Cellular action and interactions of arginine vasopressin in vascular smooth muscle: mechanisms and clinical implications. J Am Soc Nephrol 4: 2-11, 1993.
39. Seino M, Abe K, Ito S, Yasujima M, Chiba S, Hiwatari M, Sato K, Goto T, Omata K, and Tajima J. Effects of nifedipine on renal vascular responses to vasoactive agents in rabbits. Tohoku J Exp Med 142: 67-76, 1984.
40. Seino M, Abe K, Tsunoda K, and Yoshinaga K. Interaction of vasopressin and prostaglandins through calcium ion in the renal circulation. Hypertension 7: 53-58, 1985.
41. 2+ in smooth muscle of carotid artery of hypertensive rats. Br J Pharmacol 118: 857-864, 1996.
42. 2+ entry blocker. CD-349, and TMB-8 on renal vasoconstriction induced by angiotensin II and vasopressin in dogs. J Cardiovasc Pharmacol 16: 966-970, 1990.
43. Takenaka T, Suzuki H, Fujiwara K, Kanno Y, Ohno Y, Hayashi K, Nagahama T, and Saruta T. Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II. J Clin Invest 100: 2107-2114, 1997.
44. Takeuchi K, Abe K, Yasujima M, Sato M, Maeyama K, Watanabe T, Sato S, Inaba H, and Yoshinaga K. Phosphoinositide hydrolysis and calcium mobilization induced by vasopressin and angiotensin II in cultured vascular smooth muscle cells. Tohoku J Exp Med 166: 107-122, 1992.
45. 2+-ATPase. Proc Natl Acad Sci USA 87: 2466-2470, 1990.
46. 1-vascular vasopressin receptors of A7r5 cells. Endocrinology 129: 2845-2856, 1991.
47. 2+-ATPases. Trends Pharmacol Sci 19: 131-135, 1998.
48. Yuan BH, Robinette JB, and Conger JD. Effect of angiotensin II and norepinephrine on isolated rat afferent and efferent arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 258: F741-F780, 1990.